ArticleInternational journal of molecular sciences2026
Predicted
Hao Fu, Mengyao Wang, Haibo Zhu, Weihua Li, Xiaopei Shen, Haidan Yan, Jun He
Abstract read
In one paragraphArticle in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
7 authors.
Hao FuDepartment of Bioinformatics, Fujian Key Laboratory of Medical Bioinformatics, Institute of Precision Medicine, School of Medical Technology and Engineering, Fujian Medical University, Fuzhou 350122, China.ORCID 0009-0003-2725-8319 Mengyao WangDepartment of Bioinformatics, Fujian Key Laboratory of Medical Bioinformatics, Institute of Precision Medicine, School of Medical Technology and Engineering, Fujian Medical University, Fuzhou 350122, China.
Haibo ZhuDepartment of Bioinformatics, Fujian Key Laboratory of Medical Bioinformatics, Institute of Precision Medicine, School of Medical Technology and Engineering, Fujian Medical University, Fuzhou 350122, China.
Weihua LiDepartment of Bioinformatics, Fujian Key Laboratory of Medical Bioinformatics, Institute of Precision Medicine, School of Medical Technology and Engineering, Fujian Medical University, Fuzhou 350122, China.
Xiaopei ShenDepartment of Bioinformatics, Fujian Key Laboratory of Medical Bioinformatics, Institute of Precision Medicine, School of Medical Technology and Engineering, Fujian Medical University, Fuzhou 350122, China.ORCID 0000-0002-0004-4228 Haidan YanDepartment of Bioinformatics, Fujian Key Laboratory of Medical Bioinformatics, Institute of Precision Medicine, School of Medical Technology and Engineering, Fujian Medical University, Fuzhou 350122, China.
Jun HeDepartment of Bioinformatics, Fujian Key Laboratory of Medical Bioinformatics, Institute of Precision Medicine, School of Medical Technology and Engineering, Fujian Medical University, Fuzhou 350122, China.ORCID 0000-0003-1510-1093 Funding
Fujian Science and Technology Innovation Joint Fund Project 2020Y9035
6 · The paper itselfAbstract
Indexed as
Drug Resistance, NeoplasmInterferon Regulatory Factor-7MAP Kinase Signaling SystemMelanomaProto-Oncogene Proteins B-rafSTAT1 Transcription FactorAnimalsCell Line, TumorGene Expression Regulation, NeoplasticHumansMiceProtein Kinase InhibitorsBRAF protein, humanInterferon Regulatory Factor-7IRF7 protein, humanProtein Kinase InhibitorsProto-Oncogene Proteins B-rafSTAT1 protein, humanSTAT1 Transcription Factoracquired resistanceBRAF inhibitorIRF7MAPK pathway reactivationmelanomaMETsingle-cell RNA sequencingSTAT1
Identifiers
PMID42794461
PMCPMC13606645
What OpenQuestion holds
Textmetadata
Read underepoch 390